The opioid settlement funds represent one of the largest public health investments in a generation. More than $50 billion is expected to flow to states and local communities over time, creating a critical opportunity to expand treatment, strengthen recovery, and prevent overdose deaths.
But while funding will be distributed over many years, expectations for measurable impact are immediate.
Every allocation decision comes with a tradeoff. Investing in one place means not investing somewhere else. The question is no longer simply how settlement funds should be spent. It’s how to make confident decisions that maximize impact from the very beginning.
Why allocation decisions are more complicated than they appear
Settlement agreements provide broad guidance for how opioid abatement funds should be used, while giving states and local governments flexibility to determine how resources are allocated within their communities.
That flexibility is valuable. It allows investments to reflect local priorities rather than a one-size-fits-all approach.
It also makes allocation decisions more complex.
Communities vary widely in their needs, available treatment resources, and healthcare infrastructure. Overdose rates alone rarely tell the full story of where investment will have the greatest impact.
Two communities with similar overdose rates may require very different strategies. One may have treatment providers but low engagement in care. Another may have strong demand but too little provider capacity to meet it. Without a broader understanding of access, utilization, and capacity, those differences can be difficult to identify.
Looking beyond need
Most states can see where the problem is. It’s much harder to see how the system is responding to it.
Questions worth asking include:
- Where are individuals successfully accessing treatment?
- Where are gaps in access limiting care?
- Which communities have provider capacity and which do not?
- Where are individuals disengaging from treatment?
- How do utilization patterns vary across regions and populations?
Together, these insights provide a more complete picture of where investments are most likely to improve access to care and strengthen outcomes.
Turning insight into action
The opioid settlement represents a historic opportunity to strengthen systems of care for individuals with substance use disorder. Making the most of that opportunity requires more than funding alone. It requires confidence that resources are being positioned where they can have the greatest impact.
With years of experience supporting individuals with substance use disorder and serious mental illness, strengthening behavioral health networks, and helping health plans and provider partners gain a clearer understanding of performance, access, and quality data, Wayspring is well positioned to help abatement fund administrators and government agencies make informed decisions about where dollars can have the greatest impact.
By bringing together claims, utilization, and network performance data, Wayspring provides greater visibility into how communities are engaging with treatment, where gaps in access exist, and where additional resources may be needed.
As states continue investing opioid settlement dollars, the strongest decisions will be grounded in a clear understanding of where need exists, where capacity is available, and where investment can make a meaningful difference. With better visibility into behavioral health systems, communities can direct resources where they will do the most good—expanding access to care, strengthening recovery supports, and improving outcomes for the people these investments are intended to serve.